Interferon-α and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
Objective. To investigate whether an elevatedinterferon-␣(IFN␣) level early in pregnancy is associ-ated with poor pregnancy outcomes and to examine the relationship of an elevated IFN␣level to angiogenicimbalance.Methods. Women were enrolled in a longitudinalcase–control study of pregnant patients w...
- Autores:
-
Andrade, Danieli
Kim, Mimi
Blanco, Luz
Karumanchi, Ananth
Koo, Gloria
Redecha, Patricia
Kirou, Kyriakos
Álvarez Gómez, Ángela María
Mulla, Melissa
Crow, Mary K.
Abrahams, Vikki M.
Kaplan, Mariana J.
Salmon, Jane E.
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2015
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/25906
- Acceso en línea:
- http://hdl.handle.net/10495/25906
- Palabra clave:
- Lupus Vulgar
Lupus Vulgaris
Preeclampsia
Pre-Eclampsia
Lupus Eritematoso Cutáneo
Lupus Erythematosus, Cutaneous
Mujeres Embarazadas
Pregnant Women
Interferón-alfa
Interferon-alpha
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Summary: | Objective. To investigate whether an elevatedinterferon-␣(IFN␣) level early in pregnancy is associ-ated with poor pregnancy outcomes and to examine the relationship of an elevated IFN␣level to angiogenicimbalance.Methods. Women were enrolled in a longitudinalcase–control study of pregnant patients with lupus.Serum samples obtained monthly throughout preg-nancy were assayed for IFN␣and for the antiangiogenicfactor soluble Flt-1 and the proangiogenic factor pla-centa growth factor (PlGF). Each of 28 patients withsystemic lupus erythematosus (SLE) with a poor preg-nancy outcome was matched to an SLE patient with anuncomplicated pregnancy and to a pregnant healthycontrol. The effects of IFN␣and/or soluble Flt-1 onhuman endothelial cells and endothelial cell–trophoblast interactions were assessed.Results. Compared to SLE patients with uncom-plicated pregnancies, patients with preeclampsia hadincreased IFN␣levels before clinical symptoms. Pa-tients without autoimmune disease who developed pre-eclampsia did not have increased IFN␣levels. In SLEpatients with low IFN␣levels, marked angiogenic im-balance (higher soluble Flt-1, lower PlGF, and highersoluble Flt-1:PlGF ratios) preceded maternal manifes-tations of preeclampsia, whereas in SLE patients withhigh IFN␣levels, preeclampsia occurred without evi-dence of systemic angiogenic imbalance. Treatment ofhuman endothelial cells with soluble Flt-1 inducedexpression of sFLT1 messenger RNA, and IFN␣dra-matically amplified responses to soluble Flt-1. In amodel of spiral artery transformation, only the combi-nation of IFN␣and soluble Flt-1 disrupted the ability oftrophoblast cells to remodel endothelial tube structures.Conclusion. Our findings identify a new mecha-nism by which IFN␣induces an antiangiogenic milieuand increases the sensitivity of endothelial cells tosoluble Flt-1, and suggest that elevated IFN␣levels maycontribute to the pathogenesis of preeclampsia in somepregnant patients with SLE |
---|